Skin Cancers Recruiting Phase 2 Trials for Nivolumab (DB09035)

Also known as: Cancer of Skin / Skin Cancer / [X]Malignant neoplasm of skin, unspecified / Skin malignant neoplasm NOS / Malignant skin neoplasm NOS / Skin neoplasms malignant and unspecified / Skin neoplasm malignant NOS / Skin neoplasm malignant

IndicationStatusPhase
DBCOND0046599 (Skin Cancers)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03071406Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell CarcinomaTreatment